Winmill & Co’s Pfizer PFE Stock Holding History

Winmill & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-138,500	Closed	-$4.59M	–	71
2023 Q3	$4.59M	Hold	138,500	–	–	1.68%	28
2023 Q2	$5.08M	Buy	+138,500	New	+$5.39M	1.82%	23
2020 Q3	–	Sell	-84,320	Closed	-$2.62M	–	105
2020 Q2	$2.62M	Hold	84,320	–	–	1.05%	46
2020 Q1	$2.61M	Buy	84,320 +4,216	+5%	+$144K	1.42%	23
2019 Q4	$2.98M	Buy	+80,104	New	+$2.85M	1.02%	45

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Winmill & Co's PFE Position: Q4 2023 in Review

Winmill & Co sold out of Pfizer (PFE) in Q4 2023, closing a stake of 138,500 shares — an estimated $4.59M sold.

Winmill & Co first reported a position in PFE in Q4 2019 and held it in 5 quarters. The position peaked at $5.08M in Q2 2023. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Winmill & Co reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Winmill & Co sold 138,500 Pfizer shares in Q4 2023, an estimated $4.59M.
Winmill & Co first reported a position in Pfizer in Q4 2019 and held it in 5 quarters.
Winmill & Co's Pfizer position peaked at $5.08M in Q2 2023.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Winmill & Co's 13F filing for Q4 2023, filed 13 Feb 2024.